Lundbeck to measure brain with microscopic camera in new partnership

In a research collaboration with the US-based Inscopix, Lundbeck hopes to find some answers to the question of why it's so difficult to develop drugs against psychiatric disorders.

The US Food & Drug Administration's recent approval of Biogen's Alzheimer drug, Aduhelm, has sparked debate and controversy over how to measure the efficacy of medications against psychiatric and neurological disorders.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading